-
Takeda and Protagonist Announce U.S. Food and Drug Administration Accepts New Drug Application and G Rusfertide Demonstrated Significant Improvements in Hematocrit Control, Phlebotomy Reduction and Patient Reported Outcomes for Patients with Polycythemia Vera in a Pivotal Study Submission Primarily B...资讯2026-03-02
最热
